You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Conjugation
Biologically Active
Featured Product
Search results for: 'FGF'
- Active
Item 1 of 2 
Human FGF-21 [orb3002405]SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 21.69 KDa. Observed: 23 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg- Human FGFb [orb3002364]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.3 KDa. Observed: 17 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FGFb [orb3002481]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (Regularly tested)
Predicted: 17.4 KDa. Observed: 16 KDa, reducing conditions
500 μg, 1 mg, 10 μg, 50 μg - Mouse FGF-21 [orb3002387]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 20.8 KDa. Observed: 20-25 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human KGF [orb3002371]
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 20 KDa. Observed: 20-27 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse FGFb [orb3002419]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.15 KDa. Observed: 16 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Rat FGFb [orb3002420]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.2 KDa. Observed: 16 KDa, reducing conditions
10 μg, 500 μg, 1 mg, 50 μg - Human FGF-12 [orb3002303]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 20.45 KDa. Observed: 19 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human FGF-9 [orb3002310]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 23.44 KDa. Observed: 25 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg
